Sunovion Pharmaceuticals

Sunovion Pharmaceuticals

Sunovion Pharmaceuticals is creating medicines for respiratory diseases and central nervous system disorders.

No article has been written about this topic yet.
Paste a URL about this topic to auto-extract knowledge.
Visit our Writing Guide for help on how to write about a topic,
and check out an example of a well filled out topic page.

No article has been written about this topic yet.
Be the first one to add some text.

Loading AI-assisted edit mode...

Timeline

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
Mark Terry
May 22, 2020
BioSpace
"Today's approval of Kynmobi advances treatment options for people with Parkinson's disease who experience OFF episodes and the associated disruption of everyday activities," said Antony Loebel, Sunovion's president and chief executive officer.
Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.